This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia.
Blood advances, 2(3), 224-234
Citation
Maslak, Peter G; Dao, Tao; Bernal, Yvette; Chanel, Suzanne M; Zhang, Rong; Frattini, Mark; Rosenblat, Todd; Jurcic, Joseph G; Brentjens, Renier J; Arcila, Maria E; Rampal, Raajit; Park, Jae H; Douer, Dan; Katz, Laura; Sarlis, Nicholas; Tallman, Martin S; Scheinberg, David A. (2018). Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia.. Blood advances, 2(3), 224-234. https://doi.org/10.1182/bloodadvances.2017014175